The incorporation of non-natural amino acids opens up the possibility to endow proteins with properties that cannot be attained with the 20 natural amino acids encoded by DNA base triplets. The incorporation of non-natural amino acids can readily be achieved with the natural protein-translational machinery, if the structure of the modified amino acid is closely related to the natural amino acid, so that it can be loaded onto tRNA by one of the natural aminoacyl-tRNA synthetases.A wide range of non-natural amino acids has been incorporated into proteins in this way [1]. In general, the efficiency of incorporation decreases with increasing K M value of the aminoacyl-tRNA synthetase for the respective amino acid. This holds, in particular, for the in vivo incorporation of non-natural amino acids, where a pool of natural amino acids is always present. This problem can be circumvented by the use of auxotrophic strains [1] or cell-free protein production systems derived from nonauxotrophic strains combined with a suitably manipulated medium for protein synthesis [2,3].Recently, high-yield, cell-free protein production systems have become available that allow the synthesis of proteins in quantities sufficient for structural genomics applications [4][5][6][7]. High-level incorporation of seleno-methionine (Se-Met) for X-ray crystallography and fluoro-tryptophan (F-Trp) for NMR has been An Escherichia coli cell-free transcription ⁄ translation system was used to explore the high-level incorporation of l-3,4-dihydroxyphenylalanine (DOPA) into proteins by replacing tyrosine with DOPA in the reaction mixtures. ESI-MS showed specific incorporation of DOPA in place of tyrosine. More than 90% DOPA incorporation at each tyrosine site was achieved, allowing the recording of clean 15 N-HSQC NMR spectra. A redox-staining method specific for DOPA was shown to provide a sensitive and generally applicable method for assessing the cell-free production of proteins. Of four proteins produced in soluble form in the presence of tyrosine, two resulted in insoluble aggregates in the presence of high levels of DOPA. DOPA has been found in human proteins, often in association with various disease states that implicate protein aggregation and ⁄ or misfolding. Our results suggest that misfolded and aggregated proteins may result, in principle, from ribosome-mediated misincorporation of intracellular DOPA accumulated due to oxidative stress. High-yield cell-free protein expression systems are uniquely suited to obtain rapid information on solubility and aggregation of nascent polypeptide chains.Abbreviations DOPA, L-3,4-dihydroxyphenylalanine; GFP, cycle 3 mutant green fluorescent protein; hCypA, human cyclophilin A; His 6 -PpiB, N-terminal His 6 -tagged PpiB; HMP, Escherichia coli flavohaemoglobin; HSQC, heteronuclear single-quantum coherence; NBT, nitroblue tetrazolium; PpiB, E. coli peptidyl-prolyl cis-trans isomerase B; RNAP, RNA polymerase; TyrRS, tyrosyl-tRNA synthetase.